WELLS FARGO & COMPANY/MN

Position in DERM — Journey Medical Corp

CIK 72971 SAN FRANCISCO, CA

Position in DERM

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$35,178

-$86,238 QoQ

Shares Held

7,501

-52.4% QoQ

Ownership

0.027%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $924,834,595 across 59 Drug Manufacturers - Specialty & Generic names. DERM ranks #48 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	5,491,173	$649,111,558
2	UTHR	UNITED THERAPEUTICS Corp	77,138	$45,741,289
3	HLN	Haleon plc	4,022,749	$40,267,716
4	NBIX	Neurocrine Biosciences Inc	231,311	$30,472,908
5	TAK	Takeda Pharmaceutical Co Ltd	1,136,022	$21,039,125
6	ELAN	Elanco Animal Health Inc	805,422	$19,273,746
7	PBH	Prestige Consumer Healthcare Inc.	300,133	$17,788,881
8	VTRS	Viatris Inc	1,160,097	$15,672,908

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$35,178	7,501	-52.4%	Shares	Defined	2026-05-11
2025-12-31	$121,416	15,748	+109.1%	Shares	Defined	2026-02-13
2025-09-30	$53,634	7,533	+20.1%	Shares	Defined	2025-11-13
2025-06-30	$45,039	6,273	+10183.6%	Shares	Defined	2025-08-14
2024-03-31	$224	61	+1.7%	Shares	Defined	2024-05-10
2023-12-31	$345	60	+7.1%	Shares	Defined	2024-02-09
2023-09-30	$153	56	+16.7%	Shares	Defined	2023-11-13
2023-06-30	$76	48	+4.3%	Shares	Defined	2023-08-15
2023-03-31	$72	46	+4.5%	Shares	Defined	2023-05-12
2022-12-31	$84	44	+2.3%	Shares	Defined	2023-02-13
2022-09-30	$105	43	+48.3%	Shares	Defined	2022-11-14
2022-06-30	$108	29	+16.0%	Shares	Defined	2022-08-12
2022-03-31	$120	25	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.